These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7528820)

  • 41. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan.
    Hayashi J; Yoshimura E; Nabeshima A; Kishihara Y; Ikematsu H; Hirata M; Maeda Y; Kashiwagi S
    J Gastroenterol; 1994 Jun; 29(3):276-81. PubMed ID: 7520320
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam.
    Nakata S; Song P; Duc DD; Nguyen XQ; Murata K; Tsuda F; Okamoto H
    J Gastroenterol Hepatol; 1994; 9(4):416-9. PubMed ID: 7524723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.
    Mattsson L; Grillner L; Weiland O
    Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors and clinical expression of HCV infection in hemodialysis patients.
    Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA
    Nephron; 1992; 61(3):313-4. PubMed ID: 1323778
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women.
    Marranconi F; Fabris P; Stecca C; Zampieri L; Bettini MC; Di Fabrizio N; de Lalla F
    Infection; 1994; 22(5):333-7. PubMed ID: 7531180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of hepatitis C virus antibodies in the general population and in selected groups of patients in Limoges, France.
    Ranger S; Martin P; Roussanne MC; Denis F
    Gut; 1993; 34(2 Suppl):S50-1. PubMed ID: 7686115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Investigation on anti-HCV antibody in Shashi District].
    Wu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Dec; 14(6):331-3. PubMed ID: 7512448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders].
    Zenz W; Hofmann H; Muntean W
    Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of hepatitis C virus infection in multiply transfused premature neonates.
    Beeby PJ; Spencer JD; Cossart YE
    J Paediatr Child Health; 2001 Jun; 37(3):244-6. PubMed ID: 11468038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
    Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
    J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease.
    Coltorti M; Caporaso N; Morisco F; Suozzo R; Romano M; D'Antonio M
    Infection; 1994; 22(3):183-6. PubMed ID: 7523308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relative risk of hepatitis C virus transmission in polytransfused patients].
    Schujman L; Lavitula S; Maris Acebal S; Suita GR; Montero A
    Medicina (B Aires); 1994; 54(3):199-202. PubMed ID: 7854084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-HCV seroconversion in multitransfused and immunocompromised patients. A long-term longitudinal study.
    Cornu C; Brusselmans C; Geubel A; Ferrant A; Cornu G
    Vox Sang; 1994; 67(3):286-90. PubMed ID: 7532342
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A study of primary- and re-infection with hepatitis C virus in blood transfusion recipients.
    Meng ZD; Xu DG; Sun DG; Lu HY; Copland J; Liu CY; Ma XK; Chen SF; Niu JZ; Sun YD
    J Gastroenterol Hepatol; 1994; 9(3):211-6. PubMed ID: 7519893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
    Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
    Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C virus in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Carlone A; Carbone M; Manno M
    Nephron; 1992; 61(3):307-8. PubMed ID: 1323776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transmission of hepatitis C virus by anti-HCV-negative blood transfusion. Case report.
    Vrielink H; van der Poel CL; Reesink HW; Zaaijer HL; Lelie PN
    Vox Sang; 1995; 68(1):55-6. PubMed ID: 7536990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation.
    Tada K; Tajiri H; Kozaiwa K; Sawada A; Guo W; Okada S
    Transfusion; 1997 Jun; 37(6):641-4. PubMed ID: 9191826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort).
    Quaranta JF; Delaney SR; Alleman S; Cassuto JP; Dellamonica P; Allain JP
    J Med Virol; 1994 Jan; 42(1):29-32. PubMed ID: 7508489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.